According to the sources, the vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
The commissioning of these ships is of great significance for the Coast Guard, that is the nodal agency for oil spill response in India's Exclusive Economic Zone under the National Oil Disaster Contingency Plan.
'Terrorism continues to be the overwhelming threat to security and stability in the SCO region and therefore Dr Jaishankar strongly pitched for 'collective action',' observes Dr Rajaram Panda.
Adults are as likely as children to fall prey to diseases that immunisation can potentially prevent.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances